[go: up one dir, main page]

AU4503796A - Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors - Google Patents

Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors

Info

Publication number
AU4503796A
AU4503796A AU45037/96A AU4503796A AU4503796A AU 4503796 A AU4503796 A AU 4503796A AU 45037/96 A AU45037/96 A AU 45037/96A AU 4503796 A AU4503796 A AU 4503796A AU 4503796 A AU4503796 A AU 4503796A
Authority
AU
Australia
Prior art keywords
replication
tissue
compositions
diagnostic methods
specific treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45037/96A
Inventor
Yawen L Chiang
Paul L Hallenbeck
Marlene Hammer
William J Ramsey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetic Therapy Inc
US Department of Health and Human Services
Original Assignee
Genetic Therapy Inc
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Therapy Inc, US Department of Health and Human Services filed Critical Genetic Therapy Inc
Publication of AU4503796A publication Critical patent/AU4503796A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45Transferases (2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/008Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU45037/96A 1994-11-28 1995-11-28 Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors Abandoned AU4503796A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34896094A 1994-11-28 1994-11-28
US348960 1994-11-28
PCT/US1995/015431 WO1996016676A1 (en) 1994-11-28 1995-11-28 Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors

Publications (1)

Publication Number Publication Date
AU4503796A true AU4503796A (en) 1996-06-19

Family

ID=23370312

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45037/96A Abandoned AU4503796A (en) 1994-11-28 1995-11-28 Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors

Country Status (5)

Country Link
EP (1) EP0792169A1 (en)
JP (1) JPH10509879A (en)
AU (1) AU4503796A (en)
CA (1) CA2206205A1 (en)
WO (1) WO1996016676A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698443A (en) * 1995-06-27 1997-12-16 Calydon, Inc. Tissue specific viral vectors
US6265212B1 (en) 1995-06-15 2001-07-24 Introgene B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
US6783980B2 (en) 1995-06-15 2004-08-31 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
EP1445322B2 (en) 1995-06-15 2012-06-06 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
US6676935B2 (en) 1995-06-27 2004-01-13 Cell Genesys, Inc. Tissue specific adenoviral vectors
US20030044384A1 (en) 1997-10-09 2003-03-06 Pro-Virus, Inc. Treatment of neoplasms with viruses
US7780962B2 (en) 1997-10-09 2010-08-24 Wellstat Biologics Corporation Treatment of neoplasms with RNA viruses
US6670188B1 (en) 1998-04-24 2003-12-30 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
DE19856065A1 (en) * 1998-12-04 2000-06-15 Centeon Pharma Gmbh Recombinant, adenoviral vector with limited auto-replication ability in vivo
EP1390046A4 (en) 1999-04-15 2005-04-20 Wellstat Biologics Corp Treatment of neoplasms with viruses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE161039T1 (en) * 1988-10-31 1997-12-15 Univ California PRODUCTS AND METHODS FOR CONTROLLING THE SUPPRESSION OF NEOPLASTIC PHENOTYPES
US6410010B1 (en) * 1992-10-13 2002-06-25 Board Of Regents, The University Of Texas System Recombinant P53 adenovirus compositions
HU223733B1 (en) * 1993-10-25 2004-12-28 Canji, Inc. Recombinant adenovirus vector and procedure

Also Published As

Publication number Publication date
JPH10509879A (en) 1998-09-29
CA2206205A1 (en) 1996-06-06
WO1996016676A1 (en) 1996-06-06
EP0792169A1 (en) 1997-09-03

Similar Documents

Publication Publication Date Title
EP0815838A3 (en) External skin treatment composition
AU5315298A (en) Hair treatment composition containing metal-aminoacid complex
AU1844197A (en) Skin smoothing compositions containing hydroxyacids and methods for using same
AU2113295A (en) Novel compositions and methods for water treatment
AU3552195A (en) Improved patient-transport and treatment apparatus
EP0879013A4 (en) Medical guidewire
AU4406896A (en) Facial tissue carpack
AU7427498A (en) Hair treatment compositions
ZA975211B (en) Compositions and methods for administering borrelia DNA.
AU3033097A (en) Skin wash composition
ZA953256B (en) Skin treatment composition
AU3816697A (en) Conservin compositions and therapeutic and diagnostic uses therefor
AU3480297A (en) Modified mcm-56, its preparation and use
AU1575697A (en) Compositions and methods for the treatment and diagnosis of cancer
EP0612513A3 (en) External skin treatment composition.
AU4503796A (en) Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors
AU1892395A (en) Skin cleansing composition
AU3768795A (en) Method and compositions for hair treatment
AU3750395A (en) Wound treatment composition
AU5594398A (en) Methods and compositions for preventing and treating bone loss
AU2068295A (en) Skin treatment composition
AU7525496A (en) Methods and compositions comprising glut-2 and glut-2 chimeras
AU2801595A (en) Water treatment
AU9260998A (en) Hair treatment compositions
AU2593597A (en) Compositions for the diagnosis and treatment of chediak-higashi syndrome